Male Hypogonadism Workup
The workup for suspected male hypogonadism requires morning total testosterone measurement (8-10 AM) on two separate occasions combined with assessment of specific symptoms, followed by LH/FSH levels to distinguish primary from secondary hypogonadism. 1, 2
Initial Clinical Assessment
Symptom Evaluation
The diagnosis requires both biochemical confirmation and persistent specific symptoms 1:
Sexual symptoms (most specific):
- Reduced frequency of sexual intercourse 1
- Decreased libido 2
- Erectile dysfunction 2
- Reduced frequency of masturbation 1
- Delayed ejaculation 1
Physical symptoms:
Cognitive/psychological symptoms (least specific):
Critical History Elements
- Medications affecting testosterone: Opiates, glucocorticoids, GnRH agonists/antagonists, anabolic steroids, estrogens, progestogens 1
- Comorbidities: Type 2 diabetes, metabolic syndrome, obesity, chronic organ failure, HIV infection 1
- Fertility concerns: This fundamentally changes treatment approach 1, 2
- Surgical history and pituitary disorders 1
- Avoid testing during acute illness 1
Physical Examination
- Body mass index (BMI) and waist circumference 1
- Testicular volume assessment 1
- Signs of virilization 1
Laboratory Workup Algorithm
Step 1: Initial Testosterone Testing
- Morning total testosterone (8-10 AM) on two separate occasions due to assay variability 2, 3
- Free testosterone by equilibrium dialysis (especially in obesity, as SHBG is decreased) 2
- Sex hormone-binding globulin (SHBG) level 2
SHBG is decreased by: obesity, hypothyroidism, insulin resistance, metabolic syndrome, type 2 diabetes, glucocorticoids, growth hormone, anabolic steroids 1
SHBG is increased by: aging, hyperthyroidism, hepatic disease, anticonvulsants, estrogens, thyroid hormone 1
Step 2: Confirm Hypogonadism
- Total testosterone <275 ng/dL (9.54 nmol/L) confirms hypogonadism 2
- Total testosterone <8 nmol/L profoundly suggests hypogonadism 4
- Total testosterone 8-12 nmol/L represents a "grey zone" requiring symptom correlation 4
Step 3: Distinguish Primary vs Secondary Hypogonadism
If testosterone is confirmed low, measure:
Interpretation:
- Primary (hypergonadotropic) hypogonadism: Low testosterone + elevated LH/FSH (testicular dysfunction) 1, 3
- Secondary (hypogonadotropic) hypogonadism: Low testosterone + low or inappropriately normal LH/FSH (hypothalamic-pituitary dysfunction) 1, 6
- Functional hypogonadism: Normal testosterone with elevated LH, or low testosterone without organic HPG axis pathology, often due to obesity/metabolic disease 1
Additional Testing Based on Clinical Context
For Secondary Hypogonadism
- Pituitary imaging (MRI) if pituitary pathology suspected 5
- Other pituitary hormone testing if combined pituitary hormone deficiency suspected 1
For All Patients Before Treatment
- Hematocrit (baseline for monitoring erythrocytosis risk) 2, 3
- PSA and digital rectal exam in men >40 years 2, 3
- Fasting glucose and lipid panel (metabolic assessment) 2
Optional/Specialized Testing
- Semen analysis if fertility concerns 5
- Bone densitometry in long-standing hypogonadism 3, 5
- Testicular ultrasonography for structural abnormalities 5
- Genetic studies for congenital causes (Klinefelter syndrome, etc.) 5
Common Causes by Category
Primary Hypogonadism Causes
Secondary Hypogonadism Causes
- Drug-induced: Opiates, glucocorticoids, anabolic steroids 1
- Pituitary tumors (micro/macroadenomas) 1
- Idiopathic hypogonadotropic hypogonadism (including Kallmann syndrome) 1
- Hyperprolactinemia 1
- Chronic systemic diseases: Type 2 diabetes, metabolic syndrome, obesity, HIV 1
Functional Hypogonadism Triggers
Critical Pitfalls to Avoid
- Do not test testosterone during acute illness as levels are transiently suppressed 1
- Do not rely on single testosterone measurement due to pulsatile secretion and assay variability 2, 3
- Do not use screening questionnaires alone as they lack specificity 1
- Do not miss fertility assessment before initiating testosterone therapy, as it suppresses spermatogenesis 1, 2, 7
- Do not overlook reversible causes (medications, obesity) that should be addressed first 1